2018 Annual Meeting | C1 - Mild Cognitive Impairment: Implications for Clinicians
| 07:00 AM - 07:05 AM | Luncheon |
Introduction
Ronald C. Petersen, MD, PhD, FÂ鶹´«Ã½Ó³» |
| 07:05 AM - 07:50 AM | Speaker |
Overview of MCI
Ronald C. Petersen, MD, PhD, FÂ鶹´«Ã½Ó³» |
| 07:50 AM - 08:30 AM | Speaker |
Treatment and Management of MCI
David J. Gill, MD, FÂ鶹´«Ã½Ó³» |
| 08:30 AM - 09:00 AM | Q&A |
Cases, Questions, and Answers
|
| Ronald C. Petersen, MD, PhD, FÂ鶹´«Ã½Ó³» | Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| David J. Gill, MD, FÂ鶹´«Ã½Ó³» | Dr. Gill has nothing to disclose. |
| Ashley Hubbard | No disclosure on file |